Form 4: Medtronic Executive Sells Shares to Cover Taxes After Retirement Eligibility

Medtronic's Executive Vice President and President of Neuroscience, Brett A. Wall, sold 645 shares to cover taxes upon vesting of restricted stock units.

Summary

• Brett A. Wall, an Executive Vice President and President of Neuroscience at Medtronic, sold 645 ordinary shares on December 16, 2024.
• The sale was executed at a price of $82.48 per share.
• The shares were sold to cover tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Wall beneficially owns 43,708 ordinary shares, which includes 247 shares acquired through dividend reinvestment since the last report.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of any positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales for tax purposes are a common practice across publicly traded companies, including Medtronic's competitors in the medical device industry such as Abbott, Boston Scientific, and Stryker.
• These companies also have executives who regularly file Form 4s for similar transactions related to stock options and restricted stock units.
• The number of shares sold and the price are within the typical range for such transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes by an executive.

Key Dates

Keywords

Medtronic, MDT, Executive Share Sale, Form 4, Brett A. Wall, Stock Transaction, Restricted Stock Units, Tax Withholding, Insider Trading